Nanotechnology in Medicine. Группа авторов

Чтение книги онлайн.

Читать онлайн книгу Nanotechnology in Medicine - Группа авторов страница 24

Nanotechnology in Medicine - Группа авторов

Скачать книгу

and biocompatibility with living systems. The nanotechnological devices based on natural polymers have been highlighted particularly in the development of pharmaceutical systems for drug delivery, tissue engineering, and bioactivation mechanisms. The low or no‐toxicity and safety of natural polymers are essential characteristics for the use of these nanodevices in health, as will be discussed in this chapter.

      In recent years, vegetable and microbial biopolymers have gained attention due to their versatility, ecofriendly characteristics, and the possibility of sustainable and large‐scale production. In addition to the environmental concern and the need to transition from the use of synthetic polymers to polymers from renewable resources, one must also consider geopolitical factors such as conflicts in the Middle East, Russia, and Venezuela, the main oil producers in the world (Mülhaupt 2012).

      In addition to biodegradability, a hot topic due to the appeal for sustainable development and responsible use of polymers, biopolymers have been increasingly used due to their low toxicity and good biocompatibility. Nanotechnology has taken advantage of such properties for the development of tools for environmental, food, pharmaceutical, and medical applications. As previously mentioned, petroleum‐based polymers are often chemically, physically, or biologically degraded into toxic compounds that may compromise the health of living organisms. In sequence, some examples of the toxicity of relevant synthetic polymers are presented.

       ε‐caprolactam (ε‐CAP) is a precursor of nylon‐6, widely used in industry for the production of carpets, clothing, and automotive equipment, systems, components, connectors, and as additive to plastic packaging. ε‐CAP waste can migrate from plastic packaging to food. Some toxicological studies indicate the possibility of ε‐CAP causing eye and skin inflammation, as well as irritation in the respiratory system. Hypotension, tachycardia, palpitations, rhinorrhea, nasal dryness, genitourinary, and reproductive effects such as disorders in menstrual and ovarian functions, and complications in childbirth may also occur, in addition to neurological and hematological problems (Bomfim et al. 2009);

       Epoxy polymers of bisphenol‐A diglycidyl ether (DGEBA) and aliphatic polyamine co‐monomers: triethylenetetramine (TETA), 1‐(2‐aminoethyl)piperazine (AEP) and isophorone diamine (IPD) had their interactions with biological systems tested in vitro. Although the results show that DGEBA‐IPD and DGEBA‐AEP are hemocompatible and polymers based on the IPD system are not considered cytotoxic, protein adsorption tests showed that the surface of the polymers adsorbs human albumin (González Garcia et al. 2009);Table 2.1 Microbial biopolymers of industrial relevance.BiopolymerSources/micro‐organism producersChemical structureApplicationsReferencesXanthan gumBacteria from Xanthomonas genus.Backbone of repeating sub‐units, branched or not, consisting of 3–8 monosaccharides, such as D‐glucose, D‐mannose and D‐glucuronic acid. Molecular weight: up to 2000 kDa.Food Cosmetics PharmaceuticsJansson et al. (1975), Laws et al. (2001), Borges and Vendruscolo (2008), and Lopes et al. (2015)CurdlanBacteria from Agrobacterium (previously taxonomically classified as Alcaligenes), Rhizobium, Bacillus, and Cellulomonas genus.D‐glucose units linked by β‐(1➔3) glycosidic bounds. Molecular weight: up to 2000 kDa.Food Cosmetics PharmaceuticsTabernero et al. (2019)PullulanYeasts of Aureobasidium genus.Maltotriose trimer made up of α‐(1 → 6)‐linked (1 → 4)‐α‐D‐triglucosides. Molecular weight: up to 1000 kDa.Foods Cosmetics PharmaceuticsSingh et al. (2008)Gellan gumBacteria from Sphingomonas (formerly known as Pseudomonas elodea).Linear tetrasaccharide repeat unit consisting of (1➔4)‐L‐rhamnose‐(α‐1➔3)‐D‐glucose‐(β‐1➔4)‐D‐glucose‐(β‐1➔4)‐D‐glucose‐(β‐1➔). Molecular weight: ≈500 kDa.Food CosmeticsMorris et al. (2012)EmulsanAcinetobacter calcoaceticus and Acinetobacter venetianus.Polysaccharide backbone (three amino sugars in the ratio 1 : 1 : 1) with O‐acyl and N‐acyl fatty acid side chains (10–20 carbons representing 5–23% [w/w] of the polymer). The amino groups are either acetylated or covalently linked by an amide bond to 3‐hydroxybutyric acid. Molecular weight: ≈1000 kDa.Petrochemistry CosmeticsBelsky et al. (1979), Gorkovenko et al. (1997), and Panilaitis et al. (2007)AlginateAlgae (Laminaria and Ascophyllum) genus.α‐L‐guluronic and β‐D‐mannuronic acid residues linked by β‐(1–4) glycosidic bound. Molecular weight: 10–600 kDa.Food Pharmaceutics CosmeticsFAO (n.d.) http://www.fao.org/3/y4765e/y4765e07.htm and Liang et al. (2015)BotriospheranFilamentous fungus of Botryosphaeria rhodina species and some bacterial isolates.D‐glucose residues bonded by a β‐(1 → 3;1 → 6). Molecular weight: ≈4875 kDa.CosmeticsSelbmann et al. (2003) and Silva et al. (2008)Bacterial celluloseSpecies of nonpathogenic aerobic bacteria, mainly belonging to the genera Gluconacetobacter, Alcaligenes, Rhizobium, Agrobacterium, and Sarcina.β‐D‐glucopyranose units linked to each other by β‐(1➔4) glycosidic bonds.Food Pharmaceutics Cosmetics PaperIguchi et al. (2000), Belgacem and Gandini (2008), and Klemm et al. (2005)ChitosanFilamentous fungi from Mucorales genera and some bacteria.Molecular weight: 100–300 kDa.Food Pharmaceutics CosmeticsKaur et al. (2012), Campos‐Takaki et al. (2014), and Lecointe et al. (2019)Figure 2.2 Biopolymers and building blocks obtained by fermentation.Figure 2.3 Chemical structure of (a) poly(ε‐caprolactone) (PCL), (b) poly(lactic acid) (PLA), (c) poly(glycolic acid) (PGA), and (d) poly(glycolic–lactic

Скачать книгу